Cargando…
A Critical Evaluation of Wet Biomarkers for Huntington’s Disease: Current Status and Ways Forward
There is an unmet clinical need for objective biomarkers to monitor disease progression and treatment response in Huntington’s disease (HD). The aim of this review is, therefore, to provide practical advice for biomarker discovery and to summarise studies on biofluid markers for HD. A PubMed search...
Autores principales: | Silajdžić, Edina, Björkqvist, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6004896/ https://www.ncbi.nlm.nih.gov/pubmed/29614689 http://dx.doi.org/10.3233/JHD-170273 |
Ejemplares similares
-
Antibodies against phosphorylcholine are not altered in plasma of patients with Alzheimer’s disease
por: Silajdžić, Edina, et al.
Publicado: (2015) -
No Diagnostic Value of Plasma Clusterin in Alzheimer's Disease
por: Silajdžić, Edina, et al.
Publicado: (2012) -
A Metabolic Study of Huntington’s Disease
por: Nambron, Rajasree, et al.
Publicado: (2016) -
A 24-Hour Study of the Hypothalamo-Pituitary Axes in Huntington’s Disease
por: Kalliolia, Eirini, et al.
Publicado: (2015) -
Characterisation of immune cell function in fragment and full-length Huntington's disease mouse models
por: Träger, Ulrike, et al.
Publicado: (2015)